| Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients SD Solomon, N Anavekar, H Skali, JJV McMurray, K Swedberg, S Yusuf, ... Circulation 112 (24), 3738-3744, 2005 | 1005 | 2005 |
| Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ... Journal of clinical Oncology 32 (22), 2380-2385, 2014 | 696 | 2014 |
| Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction LAM Zornoff, H Skali, MA Pfeffer, M St. John Sutton, JL Rouleau, ... Journal of the American College of Cardiology 39 (9), 1450-1455, 2002 | 663 | 2002 |
| Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis R Blankstein, M Osborne, M Naya, A Waller, CK Kim, VL Murthy, ... Journal of the American College of Cardiology 63 (4), 329-336, 2014 | 661 | 2014 |
| Two‐Dimensional Assessment of Right Ventricular Function: An Echocardiographic–MRI Correlative Study NS Anavekar, D Gerson, H Skali, RY Kwong, E Kent Yucel, SD Solomon Echocardiography 24 (5), 452-456, 2007 | 486 | 2007 |
| Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM … S Kenchaiah, SJ Pocock, D Wang, PV Finn, LAM Zornoff, H Skali, ... Circulation 116 (6), 627-636, 2007 | 465 | 2007 |
| Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction SD Solomon, H Skali, NS Anavekar, M Bourgoun, S Barvik, JK Ghali, ... Circulation 111 (25), 3411-3419, 2005 | 379 | 2005 |
| Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study A Verma, A Meris, H Skali, JK Ghali, JMO Arnold, M Bourgoun, ... JACC: Cardiovascular Imaging 1 (5), 582-591, 2008 | 356 | 2008 |
| Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program SD Solomon, D Wang, P Finn, H Skali, L Zornoff, JJV McMurray, ... Circulation 110 (15), 2180-2183, 2004 | 341 | 2004 |
| Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial D Aguilar, SD Solomon, L Køber, JL Rouleau, H Skali, JJV McMurray, ... Circulation 110 (12), 1572-1578, 2004 | 333 | 2004 |
| Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction P Jose, H Skali, N Anavekar, C Tomson, HM Krumholz, JL Rouleau, ... Journal of the American Society of Nephrology 17 (10), 2886-2891, 2006 | 309 | 2006 |
| Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study) NS Anavekar, H Skali, M Bourgoun, JK Ghali, L Kober, AP Maggioni, ... The American journal of cardiology 101 (5), 607-612, 2008 | 297 | 2008 |
| Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients … MT Osborne, EA Hulten, A Singh, AH Waller, MS Bittencourt, GC Stewart, ... Journal of Nuclear Cardiology 21, 166-174, 2014 | 267 | 2014 |
| Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement … MP Tokmakova, H Skali, S Kenchaiah, E Braunwald, JL Rouleau, ... Circulation 110 (24), 3667-3673, 2004 | 259 | 2004 |
| Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both AC Pouleur, E Barkoudah, H Uno, H Skali, PV Finn, SL Zelenkofske, ... Circulation 122 (6), 597-602, 2010 | 253 | 2010 |
| Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism T Scridon, C Scridon, H Skali, A Alvarez, SZ Goldhaber, SD Solomon The American journal of cardiology 96 (2), 303-305, 2005 | 240 | 2005 |
| Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis T Vita, DR Okada, M Veillet-Chowdhury, PE Bravo, E Mullins, E Hulten, ... Circulation: Cardiovascular Imaging 11 (1), e007030, 2018 | 227 | 2018 |
| Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction AM Murcia, CH Hennekens, GA Lamas, M Jiménez-Navarro, JL Rouleau, ... Archives of internal medicine 164 (20), 2273-2279, 2004 | 219 | 2004 |
| Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction … D Castagno, H Skali, M Takeuchi, K Swedberg, S Yusuf, CB Granger, ... Journal of the American College of Cardiology 59 (20), 1785-1795, 2012 | 214 | 2012 |
| Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation MT Osborne, EA Hulten, VL Murthy, H Skali, VR Taqueti, S Dorbala, ... Journal of Nuclear Cardiology 24 (1), 86-99, 2017 | 208 | 2017 |
Scott SolomonBrigham and Women's HospitalVerified email at rics.bwh.harvard.edu
